RecruitMe Clinical Trial

Regimented Light Therapy and Sleep Schedule Modification Therapy as a Rapid, Medication-Free Treatment for Depression
The Effectiveness of Bright Lights and Regulated Sleep for the Treatment of Depression
Sponsor:Unfunded
Enrolling:Male and Female Patients
Study Length:8 Weeks
Clinic Visits:14
Age Range:Between 18 and 75 years old
IRB Number:7361
U.S. Government ID:NCT03010488
Contact: Peter Arden: 646-774-8004 / ardenpe@nyspi.columbia.edu
Additional Study Information:

Previous data suggest some depressed patients act as if their internal biological clock is out of sync with the outside world and re-aligning their clock with the timing of sunlight lessens their depressed mood and accompanying depressive symptoms. This protocol may lead to remission during the first week of treatment while causing minimal problems. Which treatment condition a participant will receive will be determined randomly (i.e., by chance, essentially a computerized flip of a coin). Prior to determination of which protocol a patient will follow, each patient will declare their desired sleep time (for example, 11 p.m. to 7 a.m.). All patients will be assigned specific times to sleep and sit in front of bright lights wearing clear or amber goggles. Assigned sleep times will differ between groups using different strategies to shift the timing of their sleep from their ideal sleep time as determined by their MEQ score to their desired sleep time. All participants will be rated daily by telephone for the first week following randomization, and then weekly for an additional five weeks. Whenever possible, weekly visits will be in person, although telephone visits will be allowed. All participants will be rated at baseline, 1 week and 6 weeks by an Independent Evaluator blind to treatment assignment (as well as the nature of the treatment and if it has occurred or not). After the six week post-randomization evaluation, all participants will be offered six months of regular psychiatric treatment and be rated monthly. Change in the symptom measures will determine treatment efficacy.Note: This study does not offer monetary compensation for participation.

Do You Qualify?
Are you addicted to alcohol or any other drugs (other than caffeine or nicotine)?YesNo
Are you currently expiriencing symptoms of depression (loss of interests, excessive low mood, etc.)?YesNo
Will you be in the New York City area for most of the next two months?YesNo
Are you currently pregnant or do you plan on becoming pregnant in the next two months?YesNo
Have you changed antidepressant medications in the past 3 months?YesNo
Investigator
Jonathan Stewart, M.D.
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:

Peter Arden

ardenpe@nyspi.columbia.edu

646-774-8004

NoYesYesNoNo5